Okumichi T, Nishiki M, Takasugi S, Toki N, Ezaki H
Cancer Res. 1984 May;44(5):2011-5.
In the present study, a trypsin inhibitor was first extracted from lung cancer tissue and purified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A final yield of 20 to 60 micrograms of inhibitor with a specific activity of 2040 units/mg of protein was obtained from 1 g of original lung cancer tissue. This inhibitor inhibited trypsin strongly, plasma kallikrein weakly, and plasmin more weakly, and its molecular weight was approximately 43,000 to 45,000 as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Its antigenicity was confirmed to be quite the same as that of human urinary trypsin inhibitor by double immunodiffusion, immunoelectrophoresis, and neutralization with anti-urinary trypsin inhibitor rabbit immunoglobulin.
在本研究中,首先从肺癌组织中提取胰蛋白酶抑制剂,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳进行纯化。从1克原始肺癌组织中最终获得了20至60微克的抑制剂,其比活性为2040单位/毫克蛋白质。该抑制剂对胰蛋白酶有强烈抑制作用,对血浆激肽释放酶抑制作用较弱,对纤溶酶的抑制作用更弱,通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定其分子量约为43,000至45,000。通过双向免疫扩散、免疫电泳以及用抗人尿胰蛋白酶抑制剂兔免疫球蛋白进行中和试验,证实其抗原性与人类尿胰蛋白酶抑制剂完全相同。